Dr. Judith Richter is an accomplished entrepreneur and among the most distinguished business leaders within the Israeli industry. Dr. Richter was Medinol's Chief Executive Officer.
Concurrent with Medinol, Dr. Richter is the founder and an active board member of several other private medical device companies – all focusing on the development of novel devices and breakthrough innovations in
the medical field.
In addition, Dr. Richter serves as a board member of Mobileye NV, listed on NYSE. Previously, Dr. Richter founded and served as the CEO of Medcon Ltd., a global provider of web-based cardiac imaging and information management.
Dr. Richter successfully led the business until it was acquired by McKesson in 2005. Among other business engagements, Dr. Richter served on the board of several Israeli corporations, including Bezeq Ltd.
Dr. Richter also held a senior position at Teva Pharmaceutical Industries Ltd., one of the largest pharmaceutical companies in the world.
Dr. Richter’s extensive experience in the industry was preceded by a career in the academia.
Dr. Richter was a faculty member for over 10 years at Tel-Aviv University’s Graduate School of Business, where she specialized in corporate strategy and decision making under uncertainty.
Today, Dr. Richter serves as a member of the Executive Committee of The Hebrew University of Jerusalem. Dr. Richter is the recipient of the Ramniceanu Prize in Economics for 2013 awarded by Tel-Aviv University in recognition for her exceptional contribution to Israel’s economic, industrial and technological development. She is also an Honorary Fellow of The Hebrew University of Jerusalem since 2013. Dr. Richter is a graduate of The Hebrew University of Jerusalem and holds a Ph.D. in Organizational Psychology from Boston University.